adxs-psa
·Code: ADXS-PSA
adxs-psa: developed by 2 companies.
adxs-psa evidence translation
What we can confirm
No verified FDA or trial count is available.
What it means
More than one developer is source-backed. Until you choose one, AI stays drug-only and does not guess ownership.
What to watch
Evidence is limited; missing information remains unknown.
BioSniper AIPage evidence connected
Prepared research question
What is verified about adxs-psa, and what remains unknown?
Run cited research
Traceable citations · Unknowns marked
See linked entities and source evidence2 indications · 0 study sponsors
Related indications
Metastatic castration-resistant prostate cancer (mCRPC), previously treated patientsmetastatic castration-resistant prostate cancer (mCRPC)
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (2)
| Company | Phase |
|---|---|
| Ayala Pharmaceuticals, Inc. (ADXS) Metastatic castration-resistant prostate cancer (mCRPC), pre… | Phase 2 |
| OLD AYALA, INC (AYLA) metastatic castration-resistant prostate cancer (mCRPC) | Phase 2 |